EXCHANGE AGREEMENTExchange Agreement • September 30th, 2024 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 30th, 2024 Company Industry JurisdictionThis Exchange Agreement (this “Agreement”), dated as of September 27, 2024, is made by and between Kiromic BioPharma, Inc., a Delaware corporation (the “Company”), and the holder of the Exchange Securities as set forth below (the “Holder”).